Table 3.
Univariate and multivariate analyses of variables that significantly affected the OS of the patients with HBV-associated ICC (n = 42).
| Variables | OS | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|---|
| 1-yr | 5-yr | HR(95%CI) | P value | HR(95%CI) | P value | |
| TACE | 88.9 | 66.7 | 0.239(0.055-1.039) | 0.039 | 0.123(0.023-0.643) | 0.013 |
| Tumor size >5 cm | 61.3 | 16.7 | 4.682(1.092-20.074) | 0.022 | 5.654(1.175-27.204) | 0.031 |
| AJCC stage 3-4 | 40.0 | 5.9 | 6.370(2.420-16.770) | <0.001 | NS | |
| LNM | 40.0 | 0 | 3.968(1.654-9.521) | 0.001 | 3.284(1.236-8.724) | 0.017 |
| CA19-9 >35kU/L | 64.3 | 14.3 | 2.968(1.000-8.809) | 0.040 | NS | |
OS: overall survival, HR: hazard ratio, CI: confidence interval, TACE: transarterial chemoembolization, AJCC: American Joint Committee on Cancer, NS: not significant, LNM: lymph node metastasis, CA19-9: carbohydrate antigen 19-9